| Identification | Back Directory | [Name]
(5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclic bis(1,2-ethanediyl acetal) | [CAS]
126690-41-3 | [Synonyms]
Ulipristal Impurity 16
17α-dihydroxy-11β-(4-N
20-bis-ethylenedioxy-5α
Ulipristal acetate intermediate N-2
N-dimethylaminophenyl)-19-norpregn-9-ene
(5a,11b)-11-(4-(dimethylamino)phenyl)-5,17-dihydroxy-19-norp...
5,6-dimethoxy-2 - (4-piperidyl) methyl-1-indenone hydrochloride
3,20-bis-ethylenedioxy-5,17-dihydroxy-11-(4-N,N-dimethylaminophenyl)-19-norpregn-9-ene
3,20-BIS-ETHYLENEDIOXY-5Α,17Α-DIHYDROXY-11Β-(4-N,N-DIMETHYLAMINOPHENYL)-19-NORPREGN-9-ENE
3,3,20,20-Bis(ethylene-dioxy) -5α, 17α-dihydroxy-11β- 4-(N,N-diMethylaMino) -phenyl -19-norpregna-9(11)-ene
3,3,3,20,20-Bis(ethylene-dioxy) -5α,17α-dihydroxy-11β-[4-(N, N-diMethylaMino)-phenyl]-19-norpregna-9(11)-ene
3,3,3,20,20-BIS(ETHYLENE-DIOXY) -5Α, 17Α-DIHYDROXY-11Β-[4-(N,N-DIMETHYLAMINO)-PHENYL]-19-NORPREGNA-9(11)-ENE
(5α,11β)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclicbis(1,2-ethanediyl acetal)
(5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclic bis(1,2-ethanediyl acetal)
3,3,3,20,20-Bis(ethylene-dioxy) -5alpha,17alpha-dihydroxy-11beta-[4-(N, N-diMethylaMino)-phenyl]-19-norpregna-9(11)-ene
(5alpha,11beta)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclic bis(1,2-ethanediyl acetal)
19-Norpregn-9-ene-3,20-dione, 11-[4-(dimethylamino)phenyl]-5,17-dihydroxy-, cyclic 3,20-bis(1,2-ethanediyl acetal), (5α,11β)- | [EINECS(EC#)]
1592732-453-0 | [Molecular Formula]
C32H45NO6 | [MOL File]
126690-41-3.mol | [Molecular Weight]
539.71 |
| Questions And Answer | Back Directory | [Application]
(5A,11B)-11-[4-(dimethylamino)phenyl]-5,17-dihydroxy-19-demethylandrost-9-ene-3,20-dione bis(1,2-ethylene glycol)cycloacetal is an intermediate of uristat acetate. Uristat acetate is a progesterone agonist/antagonist whose main action is to inhibit or delay ovulation. Uristat acetate belongs to the class of selective progesterone receptor modulators, exhibiting antagonistic and partial agonistic effects on progesterone receptors. |
|
|